Fuling Zhou

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Respiratory Syndrome Coronavirus

Long Noncoding Rna

Liquid Chromatography Tandem Mass Spectrometry

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Annals of hematology

Journal of leukocyte biology

OncoTargets and therapy

Biomarker research

This page only lists publications with an associated author ORCID identifier.

Publications

Xingruo Zeng, Yufei Lei, Shan Pan, Jiaxing Sun, Hengjing He, Di Xiao, Muhammad Jamal, Hui Shen, Fuling Zhou, Liang Shao, Quiping Zhang
LncRNA15691 promotes T-ALL infiltration by upregulating CCR9 via increased MATR3 stability. Journal of leukocyte biology 113 (2) (2023)
Xingruo Zeng, Yufei Lei, Shan Pan, Jiaxing Sun, Hengjing He, Di Xiao, Muhammad Jamal, Hui Shen, Fuling Zhou, Liang Shao, Quiping Zhang
LncRNA15691 promotes T-ALL infiltration by upregulating CCR9 via increased MATR3 stability. Journal of leukocyte biology 113 (2) (2023)
Jiamin Fang, Fuling Zhou
BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma. Annals of hematology (2023)
Natasha Mupeta Kaweme, Shu Zhou, Geoffrey Joseph Changwe, Fuling Zhou
The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applications. Biomarker research 8 (1) (2020)
Tao Liu, Guang Zeng, Huangheng Tao, Yue Shi, null null, Ting Wang, Tongzu Liu, Fangjian Guo, Fuling Zhou, Xing-Huan Wang
Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19. International journal of cancer 147 (11) (2020)
Yingying Wang, Jingfeng Li, Li Liu, Jianfang Li, Xiaoyan Liu, Jing He, Cong Wang, Dan Ye, Xinghuan Wang, Fuling Zhou
Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments. Annals of hematology 99 (8) (2020)
Yanxia Jin, Yufeng Shang, Wanggang Zhang, Lu Ding, Xiqin Tong, Honglei Tu, Guolin Yuan, Fuling Zhou
A Retrospective Analysis: A Novel Index Predicts Survival and Risk-Stratification for Bone Destruction in 419 Newly Diagnosed Multiple Myelomas. OncoTargets and therapy 12 (2019)